Lorrin Koran

Publication Details

• Duloxetine treatment of dysthymia and double depression: an open-label trial.

  Koran LM, Aboujaoude EN, Gamel NN. J Clin Psychiatry. 2007; 68 (5): 761-5

  Although not as common as major depressive disorder, dysthymia is not rare and is associated with substantial impairment. Antidepressants and some psychotherapies are often effective. We explored the efficacy of the antidepressant duloxetine, a serotonin and norepinephrine reuptake inhibitor.

  PubMedID: 17503986